1. CARDIOSTIM 2010
A dva n ce p rogra m
18th World Congress
in Cardiac Electrophysiology
& C a r d i a c Te c h n i q u e s
June 13 > 16 I 2012
Nice • FrAncE
Painting by Françoise Persil­­­­lon
Advance program
www.cardiostim.com
In collaboration with
www.cardiostim.fr 1

3. Cardiostim 2012
éditorial
European Heart Rhythm Association (EHRA) Program
A message
Wednesday June 13 / 00:00 AM Wednesday June 13 / 00:00 AM
from the Chairman of Cardiostim
CARDIAC STEM CELLS AND GENE THERAPY NEW IMAGING TECHNIQUES
Chair: Chair:
Cohen I. - Stony Brook, USA Kalman J. - Melbourne, AUS
Fast V. - Birmingham, USA Mazgalev T.N. - Cleveland, USA
• aking Hearts Regenerate
M • lectrocardiographic Imaging to Understand Arrhythmia
E
Dear Colleagues, DearCHE
Pedrazzini T. - Lausanne, Friends, Mechanisms
• ardiac Differentiation of Human Keratinocytes Derived from
C Rudy Y. - St. Louis, USA
Today is already tomorrow!
Plucked Hair Follicles • imulations to Predict Sites of VT Ablation
S
Trayanova N. A. - come. Advances
In Binah O. - were announcing revolutions in the Electrophysiology world for the years to Baltimore, USA are now on the way, and
2010, we Haifa, ISR
• RI for Risk Prediction of Arrhythmogenic Areas
M
their first applications Stem Cells from Patients the 2012 edition of Cardiostim!
• nduced Pluripotent will be discussed during with Inherited
I
Halperin H. - saved by USA
Routine ablation procedures for VT/VF, especially during electrical storms in patientsBaltimore, their ICD, robotic and 3D mapping
Arrhythmias
and navigation - Madison, USA • hat Are the Clinical Implications? management, transeptal,
W new anticoagulants in AF
January C. T. for EP and ablation techniques, contact force control,
pericardialthe robotic approaches to the left ventricle for CRT, cardiac simulation - Mannheim, DEU arrhythmia mechanisms and
• hat Are or Clinical Implications?
W
Borggrefe M. for understanding
CRT, among many others, are some of the major topics that will be introduced Discussion
• eneral and debated!
G
Rosen M. R. - New York, USA
New recommendations on palpitation management and CRT implantation and follow-up will be presented. Formerly recognized
• General Discussion
indications will be revisited, such as vaso-vagal syncope, hypertrophic cardiomyopathy or Brugada syndrome. Lots of
debates will be organized as shows and you’ll be able to give your opinion through voting systems in many of the programs settled by
the most famous experts.
What is unique in Cardiostim is the atmosphere that brings more and more people to this friendly meeting where
attendees can freely express their opinion.
That is probably why, despite the international financial crisis, more than a thousand abstracts have been received from all over the
world, and especially from countries that were not present until now in our congress, demonstrating the interest of colleagues keen to
come to Nice to present their data and debate! Congratulations to all authors for their scientific contribution.
The EHRA Program Committee members, conducted by Andreas Goette (Leipzig – Germany), participated actively in the abstract
selection in addition to the Cardiostim members. Consequently, each abstract has been reviewed by at least 6 experts. The Selection
Committee rejected 43 % abstracts overall. This year, a smaller number of oral abstract sessions is proposed to enhance the quality
of the presented material. I must congratulate and thank everyone for these difficult tasks!
As can be seen along this Advance Program, the global result of the combination of EHRA sessions with the traditional programs
proposed by our American friends and the Cardiostim Team is a high standard program that one will remind as the most complete
and attractive ever!
Our task is to translate this knowledge into understandable and useful information for clinical practice. This is why
Cardiostim also proposes educational sessions based on case presentations in the general program as well as dedicated sessions.
With the same logics, specific sessions will be dedicated to technicians and nurses.
Next June, you will enjoy Cardiostim!
The platform to consult and free download
ECG and Epidemiology data Philippe Ritter - Chairman
http://epdatabank.cardiostim.com
www.cardiostim.com 3

4. springermedizin.de
Up-to-date – Qualified –
Online
Clinical Research in Cardiology
• Current and competent survey on the diagnosis and therapy of heart and vascular diseases
• Impact Factor 2010: 3.466, rank 31/114 (Journal Citation Reports ® Thomson Reuters)
• Official Journal of the German Cardiac Society
www.crc.springer.de
Extensive
online
archive!
050357

5. Cardiostim 2012
Congress Highlights in 2012
THE EHRA PROGRAM
An extensive program was designed by the Scientific Program Committee of EHRA, and will include a total
number of 30 sessions.
HIGH-TECH ADVANCES
Among many others, four sessions will focus on new technologies that will impact our practice in the future with
the following topics: understanding of arrhythmia mechanisms and signal processing, computer simulation in
electrophysiology and CRT.
HIGH STANDARD EDUCATION
Educational material is proposed in all programs, based on Case presentations. In the EP and ablation section, a
specific program is proposed by George Klein on Saturday June 16.
In addition a Program is given in French on devices, and two sessions are dedicated to technicians and nurses.
EPDatabank by cardiostim
New in Cardiostim! Educational material is available on http://epdatabank.cardiostim.com for your own
purposes. Epidemiologic information, ECG tracings, EGMs, etc… can be downloaded for free!
Don’t hesitate to submit yours!
The platform to consult and free download
ECG and Epidemiology data
http://epdatabank.cardiostim.com
www.cardiostim.com 5

6. Advance program
Scientific Organizing Committee
CARDIOSTIM TEAM
Philippe Ritter (Bordeaux, FRA)
Pierre Bordachar, Stéphane Garrigue, Sylvain Reuter, Frédéric Sacher (Bordeaux, FRA), Mark O’Neill (London, GBR),
Vincent Probst (Nantes, FRA)
David Hayes (Rochester, USA) J.Claude Daubert (Rennes, FRA)
Douglas Zipes (Indianapolis, USA) J.Jacques Blanc (Brest, FRA)
European Heart Rhythm Association (EHRA)
President: Angelo Auricchio (Lugano, CHE)
Europace 2013 Program Committee Chairman: Andreas Götte (Magdeburg, DEU)
Vice-Chairman: John M. Morgan (Southampton, GBR)
Preparation Committee for Scientific Programs
To date, will be implemented as we go along
Abi-Samra F. M. USA Butter C. DEU Dobrev D. DEU Gorenek B. TUR
Adragao P. PRT Calkins H. USA Dodinot B. FRA Gras D. FRA
Aliot E. FRA Callans D. USA Dolan B. USA Grunnet M. DNK
Allessie M. NLD Camm A. J. GBR Dorian P. CAN Guiraudon G. M. CAN
Alonso C. FRA Cannom D. S. USA Dubner S. ARG Guirgis M. FRA
Amman P CHE Cappato R. ITA Duffy H. USA Gulizia M. ITA
Antzelevitch C. USA Capucci A. ITA Duytschaever M. BEL Hachiya H. JPN
Arnar D ICE Carlson M. D. USA Efimov I. R. USA Haigney M. USA
Asirvatham S. J. USA Cazeau S. FRA Ehrlich J. DEU Haines D. E. USA
Atie J. BRA Cha Y. M. USA Ellenbogen K. USA Haïssaguerre M. FRA
Atienza F. ESP Chen S. A. TWN El-Sherif N. USA Halimi F FRA
Auricchio A. CHE Cheng J. USA Epstein L. USA Hammill S. C. USA
Badhwar N. USA Chirife R. ARG Erdogan A. DEU Hasin Y. ISR
Behrenbeck T. USA Clemmensen P.M. DNK Ernst S. DEU Hastrup Svendse J DNK
Belott P. H. USA Cohen I. USA Exner D. CAN Hatala R. CZE
Benditt D. G. USA Cooke D. USA Ezekowitz M. D. USA Hayes D. USA
Berenfeld O. USA Coronel R. NLD Fast V. USA Healey J. S. USA
Biffi M. ITA Corrado D. ITA Fedorov V. USA Heidbüchel H. BEL
Binner L. DEU Cowie M. GBR Fermont L. FRA Helland J. USA
Blanc J. J. FRA Crijns H. J. NLD Fernandez Lozano I. ESP Hill M. USA
Blomström-Lundqvist C. WE
S Curnis A. ITA Fishman G. I. USA Hindricks G. DEU
Boersma L. NLD Danchin N. FRA Flammang D. FRA Hirao K. JPN
Bongiorni M. G. ITA Darrel F. GBR Franz M. USA Ho I. USA
Bordachar P. FRA Daubert J. C. FRA Friedman P. A. USA Hocini M. FRA
Borggrefe M. DEU Davies W. GBR Furniss S. GBR Hoffmann E. DEU
Boriani G. ITA Davy J. M. FRA Gaita F. ITA Hohnloser S. DEU
Botto G. ITA De Chillou C. FRA Gammage M. GBR Hombach V. DEU
Boveda S. FRA De Roy L. BEL Garrigue S. FRA Hornberger L. K. USA
Boyden P. A. USA Deaton C GBR Geelen P. BEL Husser D DEU
Brachmann J DEU Defaye P. FRA Geller C. DEU Iacopino S. ITA
Braunschweig F. SWE Deharo J. C. FRA Gerstenfeld E. USA Ideker R. E. USA
Breithardt G. DEU Della Bella P. ITA Gilmour R. USA Ishikawa T. JPN
Brignole M. ITA Delnoy P. P. NLD Giudici M. USA Israel C. W. DEU
Brugada P. BEL Dickstein K. NOR Goette A. DEU Jackman W. M. USA
Burri H. CHE Diener H. C. DEU Gold M. USA Jahangir A. USA
6 www.cardiostim.com

7. Cardiostim 2012
Jaïs P. FRA McGann C. USA Rhode K. GBR Sternick E. BRA
Jalife J. USA McKenna W. J. GBR Ricci R. ITA Stevenson W. G. USA
Janse M. NLD McVenes R. USA Rich M. USA Sticherling C. CHE
Jansens J. L. BEL Meine M. NLD Rinaldi A. ITA Stone P. H. USA
Jauvert G. FRA Meinertz T. DEU Rizzo G. ITA Stotts L. USA
Jordaens L. NLD Mohr F. W. DEU Roberts P. GBR Suga C. JPN
Jung W DEU Molina L. MEX Roden D. M. USA Sulke N. USA
Kaab S. DEU Mont L. ESP Rodriguez E. ESP Sutton R. MCO
Kacet S. FRA Moorman A. NLD Roguin A. ISR Svendsen J. H. DNK
Kalifa J. USA Morgan J. M. GBR Rohr S. CHE Szili-Török T. NLD
Kalman J. M. AUS Morillo C. CAN Ronaszéki A. HUN Taborsky M. CZE
Kautzner J. CZE Moss A. J. USA Rosen M. R. USA Tanel R. USA
Kay N. USA Munger T. T. USA Rosenbaum D. S. USA Thambo J. B. FRA
Keane D. USA Murgatroyd F. D. GBR Rowland E. GBR Thermistocles S. ITA
Kennergren C. SWE Myerburg R. J. USA Rozkovec A. DEU Thibault B. CAN
Kenny R. A. IRL Naccarelli G. V. USA Rudy Y. USA Thiene G. ITA
Kirchhof P. DEU Nademanee K. USA Ruffy R. USA Thijs V. BEL
Kleber A. CHE Nakagawa H. USA Ruiz-Granell R. ESP Tomaselli G. F. USA
Klein G. J. CAN Nakazato Y. JPN Ruskin J. N. USA Tondo C. ITA
Klein H. DEU Nanthakumar K. CAN Sacher F. FRA Trayanova N. USA
Klingenheben T. DEU Narayan S. M. USA Sadoul N. FRA Treede H. DEU
Klug D. FRA Natale A. USA Saffitz J. E. USA Tristani-Firouzi M. USA
Knecht S. BEL Nattel S. CAN Saghy L HUN Tse H. F. CHN
Knight B. USA Nerbonne J. USA Saksena S. USA Tseng G. N. USA
Kottkamp H. DEU Neumann T. DEU Salama G. USA Tubaro M. ITA
Krieger D. DNK Neuzil P. CZE Sanders P. FRA Turitto G. USA
Krueger M. DEU Nielsen J. C. DNK Sanguinetti M. USA Valiunas V. USA
Kuck K. H. DEU Nogami A. JPN Santini M. ITA van Gelder I. C. NLD
Kusumoto F. USA Norihisa T. JPN Santomauro M. ITA Van Gelder B. NLD
La Rovere M. T. ITA Olgin J. USA Savelieva I. GBR Van Wagoner D. R. USA
Lakatta E. USA Olshansky B. USA Saxon L. USA Vardas P. E. GRC
Lau C. P. CHN O’Neill M. GBR Schaerf R. USA Varma N. USA
Lazarus A. FRA Opthof T. NLD Schalij M. NLD Verrier R. L. CAN
Lazzara R. USA Oseroff O. ARG Scheinman M. USA Vesin J. M. CHE
Le Heuzey J. Y. FRA Oto A. TUR Schilling R. DEU Viskin S. ISR
Leclercq C. FRA Ovsyshcher E. ISR Schleich J. M. FRA Vlietstra R. USA
Leclercq J-F FRA Oyarzun R CHL Schmidt B. DEU Vogt J. DEU
Lee H. C. USA Packer D. L. USA Schmidt G. DEU Vohra J. K. AUS
Leenhardt A. FRA Padeletti L. ITA Schotten U. NLD Vos M. NLD
Lévy S. FRA Page R. L. USA Schuger C. USA Vrints C. BEL
Lewalter T. DEU Panfilov A. V. NLD Schumacher B. DEU Waldo A. L. USA
Lickfett L. DEU Pappone C. ITA Schwartz P. J. ITA Wallentin L. DEU
Linde C. M. SWE Parkhomenko A. UKR Schweikert R. USA Weiss J. USA
Linker N. J. GBR Parry S. W. GBR Schwitter J. CHE Wellens H. J. NLD
Lip GYH GBR Pedretti R. ITA Semisarian C. AUS Wieling W. NLD
Locati E. ITA Pelleg A. USA Sermasant M. FRA Wilber D. J. USA
Loh P. NDL Piccini J. USA Sethi K. IND Wilde A. M. NLD
London B. USA Piorkowski C. DEU Shah D. CHE Wilkoff B. L. USA
Love C. J. USA Poelzing S. DEU Shaw R. USA Willems S. DEU
Lubinski A. POL Pokushalov E RUS Shen W. USA Wolpert C. DEU
Mabo P. FRA Poole J. E. USA Shivkumar K. USA Xhaet O. FRA
Maier L. DEU Pratt C. M. USA Shoda M. JPN Yamada K. USA
Malik M. GBR Prinzen F. W. NLD Simantirakis E. N. GRC Yamane T. JPN
Manolis A. S. GRC Priori S. G. ITA Siu D. CHN Yang Y. USA
Mansour M. USA Pruvot E. CHE Sloman G. AUS Yu C. M. CHN
Mantovan R. ITA Prystowsky E. N. USA Smith N. GBR Zannad F. FRA
Marcus F. USA Puererfellner H. AUT Sogaard P. DNK Zareba W. USA
Markijarvi M. FIN Quinn T. GBR Sommer T. DEU Zaza A. ITA
Maron B. USA Rasmussen L. H. DNK Sperzel J. DEU Zeppenfeld K. NLD
Marrouche N. F. USA Raviele A. ITA Squarcia U. ITA Zieman S. USA
Martinek M. AUT Rea R. USA Steinbeck G. DEU Zipes D.P. USA
Mazgalev T. N. USA Reddy V. Y. USA Steinberg J. USA Zupan I. SVN
McCarty J. USA Revishvilli A. RUS Steinhaus D. USA
McElderry T. USA Reynolds D. W. USA Stern S. ISR
www.cardiostim.com 7

8. Advance program
In collaboration with
• European Heart Rhythm Association (EHRA)
• Société Française de Cardiologie
• European Society of Cardiology
• Heart Rhythm Society (HRS)
• World Society of Arrhythmias WSA/ICPES
• International Society for Holter and Noninvasive Electrocardiology (ISHNE)
• Groupe Français d’Electrophysiologie et de Stimulation Cardiaque de la Société Française de Cardiologie
• Sociedad Asociación Civil Argentina de Estimulación Cardiaca (SADEC)
• Asian-Pacific Society of Cardiology
• Brazilian Society of Cardiology
• Latin-American Society of Pacing and Electrophysiology (SOLAECE)
• Artificial Cardiac Electrostimulation Department of the Brazilian Cardiac Surgery Group (DECA)
• Associazione Italiana di Aritmologia e Cardiostimolazione (AIAC)
• Mediterranean Society of Pacing and Electrophysiology (MESPE)
• he RETAC Group (Reunion of European countries for the Treatment of Arrhythmias in Cardiology/Réseau Européen
T
pour le Traitement des Arythmies Cardiaques)
CME ACCREDITATION
EHRA SESSIONS at CARDIOSTIM 2012 are currently under review for accreditation by the European Board
for Accreditation in Cardiology (EBAC) for external CME credits.
The accreditation results will be announced online and in the final program.
Subscribe to Cardiostim newsletter
✓ on www.cardiostim.com
8 www.cardiostim.com

9. Cardiostim 2012
Contents
European Heart Rhythm Association (EHRA) Program.............................................................................................. P. 10
Basic Electrophysiology.............................................................................................................................................. P. 19
Complex Electrophysiology and Ablation Techniques.............................................................................................. P. 23
• Novel Approaches to Apply Mechanistic Insights to Complex Human Arrhythmias
Treatments for Atrial Fibrillation................................................................................................................................. P. 29
• Advances and Controversies in Atrial Fibrillation (ACAF)
Noninvasive Electrocardiology.................................................................................................................................... P. 30
• Educational Symposium of International Society for Holter and Noninvasive Electrocardiology (ISHNE)
Main Trials in the Management of Atrial Fibrillation.................................................................................................. P. 34
Acute Cardiac Care: Management of SCD.................................................................................................................. P. 35
Pacing, ICDs and CRT.................................................................................................................................................. P. 36
Leads............................................................................................................................................................................ P. 43
Associate Symposia.................................................................................................................................................... P. 45
• Cardiostim / HRS Joint Session
• Cardiopace
• Vaso Vagal Syncope
• Geriatric Cardiology
• Asia Pacific Cardiostim Symposium
• Palpitations
• Fetal Cardiology Symposium
• Pediatric Cardiac Electrophysiology
• Cardiostim-JHRS Joint Session
• Syncope
• ICE Program
• Italian Cardiostim Symposium
• EPIC Alliance
Industry Symposia....................................................................................................................................................... P. 53
Symposium STIMUPRAT.............................................................................................................................................. P. 59
The publisher and the Cardiostim organization disclaim any liability for errors or omissions that may come to light,
despite the care taken in the production of this Advance Program.
www.cardiostim.com 9

10. Advance program
European Heart Rhythm Association (EHRA) Program
Organized by
the Scientific Committee of EHRA,
Coordination, Program Committee Andreas Götte - Magdeburg, DEU
Wednesday June 13 / 9:00 - 10:30 Wednesday June 13 / 9:00 - 10:30
CRT IN THE 21ST CENTURY. WHAT DO WE NEW INSIGHTS IN BASICS OF ARRHYTHMIAS
HAVE NOW? STATUS QUO AND QUO VADIS? Chair:
Chair: Crijns H. J. - Maastricht, NLD
Boriani G. - Bologna, ITA Savelieva I. - London, GBR
Kuck K. H. - Hamburg, DEU
• alcium Handling and Arrhythmias: A Link to Be Targeted
C
• RT in Ischemic Heart Failure Patients: From Cell Function to
C Zaza A. - Milano, ITA
Clinical Outcome • Nodes» in the Arrhythmia Pathogenetic Network
«
Auricchio A. - Lugano, CHE Schotten U. - Maastricht, NLD
• RT in Patients with Atrial Fibrillation
C • itochondrial Dysfunction and Arrhythmias
M
Vardas P. E. - Heraklion, GRC O’Rourke B. - Baltimore, USA
• wo Years with New Guidelines. Do We Have Unresolved
T • linical Evidence and Possible Therapy of These Arrhythmias
C
Questions? Van Gelder I. C. - Groningen, NLD
Dickstein K. - Stavanger, NOR
• RT in Narrow QRS
C
Ponikowski P. - Wroclaw, POL
Wednesday June 13 / 9:00 - 10:30 Wednesday June 13 / 9:00 - 10:30
PACEMAKER THERAPY IN YEAR 2012 ION CHANNELOPATHIES
Chair: Chair:
Simantirakis E. N. - Heraklion, GRC Jalife J. - Ann Arbor, USA
Oyarzun R. - Santiago, CHL Kaab S. - Munchen, DEU
• ow Important Is Minimization of RV Pacing?
H • ong QT Syndrome - Types and Therapies
L
Israel C. W. - Bielefeld, DEU Priori S. G. - Pavia, ITA
• R Safe Pacemakers
M • rugada Syndrome - Place of Ion Channel Antiarrhythmic
B
Davy J. M. - Montpellier, FRA Drugs
Wolpert C. - Mannheim, DEU
• here in the RV Should Ventricular Pacing Be Applied?
W
Butter C. - Bernau, DEU • Wave Syndromes
J
Antzelevitch C. - Utica, USA
• hould AAI Pacing Be Considered Obsolete?
S
Nielsen J. C. - Aarhus, DNK • diopathic Ventricular Fibrillation - Does It Exist?
I
Wilde A. M. - Amsterdam Zuidoost, NLD
10 www.cardiostim.com

11. Cardiostim 2012
European Heart Rhythm Association (EHRA) Program
Wednesday June 13 / 11:00 - 12:30 Wednesday June 13 / 11:00 - 12:30
CRT: READING THE GUIDELINES WHAT A DEVICE SPECIALIST NEEDS TO KNOW
Chair: ABOUT HEART FAILURE
Auricchio A. - Lugano, CHE Chair:
Kirchhof P. - Birmingham, GBR Daubert J. C. - Rennes, FRA
Ponikowski P. - Wroclaw, POL
• RT in Mild Heart Failure
C
Linde C. M. - Stockholm, SWE • acing in Heart Failure: What Happens on the Cellular Level?
P
• RT in Atrial Fibrillation
C Vanderheyden M. - Aalst, BEL
Sutton R. - Monaco, MCO • ptimal Medical Treatment in Heart Failure
O
• RT in Patients with Conventional Pacemaker Indications
C Cowie M. - London, GBR
Burri H. - Geneva, CHE • he Device Patient with End Stage Heart Failure
T
• RT in Clinical Practice: The European CRT Survey
C Fruhwald F. - Graz, AUT
Dickstein K. - Stavanger , NOR • ole of Implantable Sensors in Heart Failure Management
R
Braunschweig F. - Stockholm, SWE
Wednesday June 13 / 11:00 - 12:30
PURKINJE FIBERS AND VENTRICULAR
ARRHYTHMIAS
Chair:
Kuck K. H. - Hamburg, DEU
Leclercq J. F. - Levallois, FRA
• rrhythmia of Purkinje Fibers: Specificity of Cellular
A
Mechanisms
Ehrlich J. - Frankfurt, DEU
• ffect of Antiarrhythmic Drugs on the Purkinje Network:
E
Electrophysiological and Pharmacological Aspects
Vos M. - Utrecht, NLD
• blation of Polymorphic VT in Patients with Structural Heart
A
Disease
TBD
• diopathic VF Originating from the Purkinje Network: Ablation
I
Targets and Long-Term Follow-Up
Knecht S. - Brussels, BEL
www.cardiostim.com 11

12. Advance program
European Heart Rhythm Association (EHRA) Program
Wednesday June 13 / 14:00 - 15:30 Wednesday June 13 / 16:00 - 17:30
NEW EHRA DOCUMENTS ICD THERAPY IN YEAR 2012
Chair: Chair:
Raviele A. - Venice, ITA Garrigue S. - Bordeaux, FRA
Svendsen J. H. - Copenhagen, DNK
• alpitations
P
Raviele A. - Venice, ITA • efibrillation Testing during Implant: To Do or Not to Do?
D
• leeding Risk
B Baensch D. - Rostock, DEU
Lip G. Y. - Birmingham, GBR • ow to Reduce Inappropriate Shock Therapy
H
• ICD for Life’ Initiative-Fighting against Sudden Cardiac Death
‘ Wolpert C. - Mannheim, DEU
in Emerging Economies. • eliability of Implantable Devices and Leads - Are They Good
R
Merkely B. - Budapest, HUN Enough?
• enetic Testing
G Steinhaus D. M. - Mounds View, USA
Priori S. G. - Pavia, ITA • ow Should We Program Tachy Parameters in ICDs.
H
Zupan I. - Ljubljana, SVN
Wednesday June 13 / 14:00 - 15:30 Wednesday June 13 / 16:00 - 17:30
SUDDEN CARDIAC DEATH IN THE YOUNG STATE-OF-THE ART ON VENTRICULAR
Chair: TACHYCARDIA ABLATION
Heidbüchel H. - Leuven, BEL Chair:
Morgan J. M. - Southampton, GBR De Chillou C. - Nancy, FRA
Wellens H. J. - Maastrisht, NLD
• utopsy Rate and Cause of Death in the Young: A National
A
Study from Denmark • ndocardial Catheter Ablation of Monomorphic VT: From
E
Winkel B. G. - Copenhagen, DNK Bench to EP Lab
• rugada Syndrome: Not as Dangerous as First Assumed?
B Atie J. - Rio do Janeiro, BRA
Borggrefe M. - Mannheim, DEU • picardial Approach: A First Line Therapy?
E
• ow Should We Make a Work-Up in Young Cardiac Arrest
H Della Bella P. - Milano, ITA
Survivors? • ew Mapping and Ablation Strategies for Catheter Ablation of
N
Braunschweig F. - Stockholm, SWE VT in Patients with Dilated Cardiomyopathies
• oronary Abnormalities and Sudden Cardiac Death
C Piorkowski C. - Leipzig, DEU
Ho S. Y. - London, GBR • ombined Ablation Endo-Epicardial Approach for VT Ablation
C
Kottkamp H. - Zurich, CHE
12 www.cardiostim.com

13. Cardiostim 2012
European Heart Rhythm Association (EHRA) Program
Thursday June 14 / 09:00 - 10:30 Thursday June 14 / 11:00 - 12:30
PREVENTING SUDDEN CARDIAC DEATH WITH HIGHLIGHTS FROM EUROPACE 2011: DEVICE
RF ABLATION THERAPY, INTERVENTIONAL EP AND MEDICAL
Chair: THERAPY
Haïssaguerre M. - Pessac, FRA Chair:
Mont L. - Barcelona, ESP Auricchio A. - Lugano, CHE
Hindricks G. - Leipzig, DEU
• apping and Ablation of Idiopathic Ventricular Fibrillation
M
Sacher F. - Bordeaux, FRA • nterventional EP
I
• revention of VF Episodes in Brugada Syndrome by Catheter
P Merino J. L. - Madrid, ESP
Ablation • harmacotherapy
P
Merino J. L. - Madrid, ESP Camm A. J. - London, GBR
• ombined Endocardial and Epicardial Ablation in Patients with
C • acing
P
ARVD Vardas P. E. - Heraklion, GRC
Wissner E. - Hamburg, DEU
• efibrillation and CRT-D
D
• atheter Ablation of Ventricular Electrical Storms
C Wolpert C. - Mannheim, DEU
Atie J. - Rio do Janeiro, BRA
Thursday June 14 / 09:00 - 10:30
STROKE PREVENTION IN ATRIAL FIBRILLATION:
STATE-OF-THE ART AND NEW CONCEPTS
Chair:
Camm A. J. - London, GBR
Rasmussen L. H. - Aalborg, DNK
• asic Science Insights into the Prothrombotic State in Atrial
B
Fibrillation
De Caterina R. - Chieti, ITA
• linical Trial Update - What Do the RELY, ROCKET,
C
ARISTOTLE and AVERROES Trials Tell Us?
Lip G. Y. - Birmingham, GBR
• oes Aspirin Still Have a Role in Atrial Fibrillation?
D
Grond M. - Berlin, DEU
• hat Should the New Guideline Revisions on Stroke
W
Prevention Look Like?
Kirchhof P. - Birmingham, GBR
www.cardiostim.com 13

14. Advance program
European Heart Rhythm Association (EHRA) Program
Thursday June 14 / 14:00 - 15:30 Thursday June 14 / 16:00 - 17:30
CRT IMPLANTATION AND FOLLOW-UP: THE CHALLENGES OF THE ASYMPTOMATIC
EHRA-HRS CONSENSUS STATEMENT PATIENT IN HEREDITARY SYNDROMES
Chair: Chair:
Daubert J.C. - Rennes, FRA Priori S. G. - Pavia, ITA
Saxon L. - Los Angeles, USA Wolpert C. - Mannheim, DEU
• re-Implant Evaluation
P • symptomatic Patient with Long QT Syndrome
A
Brignole M. - Lavagna, ITA Schulze-Bahr E. - Munster, DEU
• mplantation
I • symptomatic Patient with Brugada Syndrome
A
Singh J. - Boston, USA Brugada Terradellas P. - Brussels, BEL
• re-Discharge Evaluation
P
• symptomatic Patient with Early Repolarization Syndrome
A
Leclercq C. - Rennes, FRA
Haïssaguerre M. - Bordeaux, FRA
• evice and Heart Failure Follow-Up
D
Israel C.W. - Frankfurt, DEU • symptomatic Patient with Catecholaminergic Polymorphic VT
A
• esponse to CRT
R Wanguemert Perez F. - Las Palmas, ESP
Gold M. - Charleston, USA
• pecific Issues
S
Saxon L. - Los Angeles, USA
Thursday June 14 / 16:00 - 17:30 Thursday June 14 / 16:00 - 17:30
CONTEMPORARY CONSIDERATIONS BASED ON TRANSLATIONAL APPROACHES IN ATRIAL
TECHNOLOGICAL DEVELOPMENTS IN CARDIAC FIBRILLATION
PACING Chair:
Chair: Zaza A. - Milano, ITA
Botto G. - Como, ITA Goette A. - Magdeburg, DEU
Sutton R. - Monte Carlo, MCO
• enes and Mutations in Patients with Lone Atrial Fibrillation:
G
• hould All Permanent Pacemakers Be MRI Compatible?
S Do They Matter?
Santini M. - Roma, ITA Olesen M. - Copenhagen, DNK
• s Telemonitoring a New Necessity?
I • onic Remodelling: From Bench to Bedside
I
Burri H. - Geneva, CHE Van Gelder I. C. - Groningen, NLD
• eadless Pacing: A Step Forward?
L • tructural Remodeling: Which Impact for Catheter Ablation?
S
Roberts P. - Southampton, GBR Schotten U. - Maastricht, NLD
• iological Pacemakers: A Futuristic Approach?
B • trial and Ventricular Oxidatives Stress during Atrial
A
Israel C. W. - Bielefeld, DEU Fibrillation
Lendeckel U. - Greifswald, DEU
14 www.cardiostim.com

15. Cardiostim 2012
European Heart Rhythm Association (EHRA) Program
Friday June 15 / 09:00 - 10:30 Friday June 15 / 11:00 - 12:30
IMPROVING OUTCOMES IN THE CATHETER COMPLICATIONS RELATED TO ATRIAL
ABLATION OF ATRIAL FIBRILLATION FIBRILLATION CATHETER ABLATION
Chair: Chair:
Kautzner J. - Praha, CZE Gaita F. - Asti, ITA
Kuck K. H. - Hamburg, DEU Hatala R. - Bratislava, SVK
• enervation of the Heart. The Role of gP Ablation in Atrial
D • revalence and Predictors of Complications of Radiofrequency
P
Fibrillation Treatment Catheter Ablation for Atrial Fibrillation
Pokushalov E. - Novosibirsk, RUS Kautzner J. - Praha, CZE
• arly Ablation of Atrial Fibrillation. Would We Have Better
E • atheter Ablation on Uninterrupted Warfarin: Is It Safe?
C
Long-Term Results in the Future? Schilling R. - London, GBR
Kirchhof P. - Birmingham, GBR • ncidence of Silent Cerebral Thromboembolic Lesions after
I
• atheter Ablation of the Long-Standing Persistent Atrial
C Atrial Fibrillation Ablation: Predictive Factors?
Fibrillation. Where We Are Now? Scaglione M. - Asti, ITA
Willems S. - Hamburg, DEU • ong-Term Rates of Death, Stroke, and Dementia Following
L
• urrent Standard of Care in Atrial Fibrillation Ablation
C Atrial Fibrillation Ablation
Jaïs P. - Bordeaux, FRA Day J. - Salt Lake City, USA
Friday June 15 / 09:00 - 10:30 Friday June 15 / 11:00 - 12:30
THE COMPLEX PACEMAKER IMPLANTATION CONTINUOUS MONITORING IN ATRIAL
Chair: FIBRILLATION MANAGEMENT. NEW SCIENCE
Davy J. M. - Montpellier, FRA OR NEW TRUTH?
Ponikowski P. - Wroclaw, POL Chair:
Lewalter T. - Bonn, DEU
• evice Implant in Case of Subclavian Vein Occlusion
D Zupan I. - Ljubljana, SVN
Bracke F. - Eindhoven, NLD
• mplantation of a Pacing System in GUCH Patients
I • ymptomatic/Asymptomatic Events after AF Ablation
S
Morgan J. M. - Southampton, GBR Hindricks G. - Leipzig, DEU
• acing Considerations in Pediatric Patients
P • nticoagulation/Antiarrhythmic Management after AF Ablation
A
Cantu F. - Bergamo, ITA Kirchhof P. - Birmingham, GBR
• acemaker Therapy after TAVI Procedure
P • F Burden in Assessment of Long-Term Success after AF
A
Wissner E. - Hamburg, DEU Ablation
Puererfellner H. - Linz, AUT
• anagement of Early Post-Operative Period. Who Will Need
M
Early Reablation?
Pokushalov E. - Novosibirsk, RUS
www.cardiostim.com 15

16. Advance program
European Heart Rhythm Association (EHRA) Program
Friday June 15 / 14:00 - 15:30 Friday June 15 / 16:00 - 17:30
ADVANCES IN ROBOTIC AND 3D MAPPING DIAGNOSTIC EVALUATION OF SYNCOPE IN
TECHNOLOGIES FOR ATRIAL FIBRILLATION SPECIAL PATIENT GROUPS
ABLATION Chair:
Chair: Morgan J. M. - Southampton, GBR
Kautzner J. - Praha, CZE Theodorakis G. - Athens, GRC
Santini M. - Roma, ITA
• atients with Bundle Branch Block
P
• emote Magnetic Catheter Navigation: Is It the «Gold Standard»?
R Moya A. - Barcelona, ESP
Ernst S. - Hamburg, DEU • yncope in Athletes
S
• ethods, Efficacy, and Safety of Robotic Catheter Ablation for
M Flevari P. - Halandri, GRC
Atrial Fibrillation • yncope in the Elderly: Particularities
S
Pisapia A. - Marseille, FRA Kenny R. A. - Dublin, IRL
• hree-Dimensional Rotational Angiography: A New Online
T • yncope Unit: A New Necessity?
S
Imaging Tool Brignole M. - Lavagna, ITA
Noelker G. - Bad Oeynhausen, DEU
• atheter Ablation of Atrial Fibrillation Using a New Non-
C
Fluoroscopic Sensor-Guided 3D Navigation Tool
Hindricks G. - Leipzig, DEU
Friday June 15 / 14:00 - 15:30 Friday June 15 / 16:00 - 17:30
MANAGEMENT OF PATIENTS WITH ARRHYTHMIAS IN WOMEN: STATE OF THE
DEFIBRILLATOR SHOCKS: STATE-OF-THE ART EVIDENCE
Chair: Chair:
Boriani G. - Bologna, ITA Borggrefe M. - Mannheim, DEU
Morgan J. M. - Southampton, GBR Heidbüchel H. - Leuven, BEL
• ncidence, Predictors and Impact on Mortality
I • anaging Arrhythmias in Pregnancy: What’s in the Guidelines?
M
van Rees H. - Den Haag, NLD Blomstrom-Lundqvist C. - Uppsula, SWE
• CD Configuration and Programming to Optimise Shock
I • ender Differences in Atrial Fibrillation
G
Treatment Mont L. - Barcelona, ESP
Katz A. - Ashkelon, ISR • utcomes in Women Undergoing Electrophysiological
O
• esults of Catheter Ablation in Patients with Shocks
R Procedures
Arenal Maiz A. - Madrid, ESP Santangeli P. - Austin, USA
• ow to Manage Patient Anxiety
H • mplantable Cardioverter Defibrillators in Women
I
Ladwig K. H. - München, DEU Zupan I. - Ljubljana, SVN
16 www.cardiostim.com

17. Cardiostim 2012
European Heart Rhythm Association (EHRA) Program
Friday June 15 / 16:00 - 17:30 Saturday June 16 / 09:00 - 10:30
NEW ENERGIES AND TECHNOLOGIES TO TREAT CERTIFICATION: FIGHTING AGAINST INEQUALITY
ATRIAL FIBRILLATION IN HEALTH CARE ACROSS BORDERS
Chair: Chair:
Davies W. - London, GBR Auricchio A. - Lugano, CHE
Kuck K. H. - Hamburg, DEU Nielsen J. C. - Aarhus, DNK
• apping and Pulmonary Vein Isolation Using the PVAC
M • Powerful Tool for Improvement in Health Care
A
Duytschaever M. - Brugges, BEL Zeppenfeld K. - Leiden, NLD
• ryoballoon Pulmonary Vein Isolation Guided by Real-Time PV
C • odels to Be Listened: UK
M
Potential Recording Linker N. J. - Middlesbrough, GBR
Hoffmann E. - Munich, DEU • ertification of Allied Professionals
C
• ow-Level Vagosympathetic Nerve Stimulation: A New Target
L Nolan P. - Galway, IRL
for Atrial Fibrillation Suppression? • ertification in Europe: Differences with and Lessons from USA
C
Jackman W. M. - Oklahoma City, USA Arribas Ynsaurriaga F. - Madrid, ESP
• inimally Invasive Surgical Techniques: For Which Patients?
M
La Meir M. - Maastricht, NLD
Saturday June 16 / 09:00 - 10:30
DEBATES AND CONTROVERSIES IN THE
ANTITHROMBOTIC MANAGEMENT OF ATRIAL
FIBRILLATION
Chair:
Savelieva I. - London, GBR
• ow Risk Patients with Atrial Fibrillation Can Be Treated with
L
No Antithrombotic Therapy: FOR
Fauchier L. - Tours, FRA
• ow Risk Patients with Atrial Fibrillation Can Be Treated with
L
No Antithrombotic Therapy: AGAINST
Rasmussen L. H. - Aalborg, DNK
• ntiplatelet Therapy Should Be Added to Anticoagulant Therapy
A
in Patients with Atrial Fibrillation and Vascular Disease: FOR
Rubboli A. - Bologna, ITA
• ntiplatelet Therapy Should Be Added to Anticoagulant Therapy
A
in Patients with Atrial Fibrillation and Vascular Disease: AGAINST
Marin F. - Murcia, ESP
www.cardiostim.com 17

18. Advance program
European Heart Rhythm Association (EHRA) Program
Saturday June 16 / 11:00 - 12:30 Saturday June 16 / 11:00 - 12:30
ANTIARRHYTHMIC DRUGS FOR ATRIAL NURSE-LED INTERVENTIONS FOR PATIENTS
FIBRILLATION WITH ARRHYTHMIAS
Chair: Chair:
Capucci A. - Ancona, ITA Linker N. J. - Middlesbrough, GBR
van Gelder I. C. - Groningen, NLD Zeppenfeld K. - Leiden, NLD
• asics of Ion Channel Antiarrhythmic Drugs for Prevention of
B • OPE-ICD Trial: Comprehensive Rehabilitation for Patients
C
Atrial Fibrillation with Implantable Defibrillators
Dobrev D. - Heidelberg, DEU Kikkenborg Berg S. - Copenhagen, DNK
• asics of Upstream Therapies for Prevention of Atrial Fibrillation
B • educing Psychological Distress for Patients with Implantable
R
Goette A. - Magdeburg, DEU Defibrillators
• on Channel Antiarrhythmic Drugs for Prevention of Atrial Fibrillation
I Dunbar S. - Atlanta, USA
Crijns H. J. - Maastricht, NLD • mplementing a Nurse-Led Atrial Fibrillation Clinic
I
• pstream Therapies for Prevention of Atrial Fibrillation
U Hendriks J. M. L. - Maastricht, NLD
Savelieva I. - London, GBR • alpitations: Effectiveness of A Nurse-Led Clinic
P
Smallwood A. - Wolverhampton, GBR
In parallel with the scientific sessions, EHRA will hold a General Assembly to update members and attendees on its activities, while
meetings of various committees and working groups will take place throughout the Congress.
EHRA Membership 2012, DISCOVER YOUR BENEFITS ON OUR WEB SITE
• pecial registration fee for EHRA educational courses
S
• ree registration for the EHRA Webinars (e-learning)
F
• 5% discount on EHRA Certification Examinations
1
• 10% off all cardiology publications from Oxford University Press (OUP).
• Reduced fee for the EP Europace journal
• xclusive access to EHRA Training Fellowships and a selection of EHRA Educational Content Online
E
• utomatic ESC membership and benefits: Free ESC Pocket Guidelines at the ESC Congress,
A
Discount prices on the ESC Educational Products, Special subscription prices on ESC Journals
(including EHJ), Receive ESC congresses related information, Receive ESC Educational Programme
information, A personal European Membership Card (currently for members of some National Cardiac
Societies only)
• Receiving the EHRA E-newsletter
• Voting rights
More at WWW.ESCARDIO.ORG/EHRA
18 www.cardiostim.com

19. Cardiostim 2012
Basic Electrophysiology
Chairman: D. Zipes - Indianapolis, USA
Scientific Committee
Ackerman M. - Rochester, USA Nattel S. - Montreal, CAN
Anderson M.E. - Iowa City, USA Priori S. G. - Pavia, ITA
Antzelevitch C. - Utica, USA Roden D.M. - Nashville, USA
Borggrefe M. - Mannheim, DEU Rosen M. R. - New York, USA
Boyden P. - New York, USA Rosenbaum D.S. - Cleveland, USA
Chen P.S. - Indianapolis, USA Rudy Y. - St Louis, USA
Delmar M. - New York, USA Saffitz J. - Boston, USA
Ideker R. - Birmingham, USA Schwartz P. J. - Pavia, ITA
Jalife J. - Ann Arbor, USA Tomaselli G. - Baltimore, USA
Kleber A. - Bern, CHE Trayanova N. A. - Baltimore, USA
London B. - Pittsburgh, USA Weiss J. - Los Angeles, USA
Mazgalev T.N. - Cleveland, USA Wilde A. M. - Amsterdam Zuidoost, NLD
Moss A.J. - Rochester, USA
TRANSLATIONAL DISCOVERIES IN CARDIAC ELECTROPHYSIOLOGY: From Cell to Bedside
Wednesday June 13 / 09:00 - 10:30 Wednesday June 13 / 11:00 - 12:30
CARDIAC STEM CELLS AND GENE THERAPY NEW IMAGING TECHNIQUES
Chair: Chair:
Cohen I. - Stony Brook, USA Kalman J. - Melbourne, AUS
Fast V. - Birmingham, USA Mazgalev T.N. - Cleveland, USA
• aking Hearts Regenerate
M • lectrocardiographic Imaging to Understand Arrhythmia
E
Pedrazzini T. - Lausanne, CHE Mechanisms
• ardiac Differentiation of Human Keratinocytes Derived from
C Rudy Y. - St. Louis, USA
Plucked Hair Follicles • imulations to Predict Sites of VT Ablation
S
Binah O. - Haifa, ISR Trayanova N. A. - Baltimore, USA
• RI for Risk Prediction of Arrhythmogenic Areas
M
• nduced Pluripotent Stem Cells from Patients with Inherited
I
Halperin H. - Baltimore, USA
Arrhythmias
• hat Are the Clinical Implications?
W
January C. T. - Madison, USA
Borggrefe M. - Mannheim, DEU
• hat Are the Clinical Implications?
W • eneral Discussion
G
Rosen M. R. - New York, USA
• General Discussion
www.cardiostim.com 19

20. Advance program
Basic Electrophysiology
Wednesday June 13 / 14:00 - 15:30 Thursday June 14 / 09:00 - 10:30
MYOCYTE-FIBROBLAST INTERACTIONS IN CONTRIBUTION OF GENETICS TO
NORMAL AND DISEASED MYOCARDIUM UNDERSTANDING MECHANISMS AND RISK
Chair: Chair:
Kleber A. - Bern, CHE Sanders P. - Adelaide, AUS
Vos M. - Utrecht, NLD Lazzara R. - Oklahoma City, USA
• yocyte Fibroblast Interaction
M • xperimental Models to Explain Inherited Diseases
E
Kohl P. - London, GBR Antzelevitch C. - Utica, USA
• yofibroblasts as Arrhythmia Triggers
M • athology to Explain Phenotype
P
Rohr S. - Bern, CHE Basso C. - Padova, ITA
• lectromechanical Consequences of Adult Cardiomyocyte
E • ellular Electrophysiology to Explain Clinical Phenotypes
C
Myofibroblast Interactions Napolitano C. - Pavia, ITA
Jalife J. - Ann Arbor, USA
• hat Are the Clinical Implications?
W
• hat Are the Clinical Implications?
W Moss A. J. - Rochester, USA
Duffy H. - Boston, USA
• General Discussion
• General Discussion
Wednesday June 13 / 16:00 - 17:30 Thursday June 14 / 11:00 - 12:30
CARDIAC ION CHANNELS AND DOES GENETIC TESTING FOR SUDDEN DEATH
MACROMOLECULAR COMPLEXES IN HEALTH HELP IN CLINICAL PRACTICE?
AND DISEASE Chair:
Chair: Tseng G. N. - Richmond, USA
Fishman G. - New York, USA Priori S. G. - Pavia, ITA
Fedorov V. - Columbus, USA
• Syndrome
• acromolecular Complexes and the Control of Cardiac Ion
M Schwartz P. J. - Pavia, ITA
Channel Expression and Distribution • rugada Syndrome and CPVT
B
Abriel H. - Bern, CHE Brugada P. - Aalst, BEL
• ntercalated Disc as a Macromolecular Complex Niche and Its
I • Hypertrophic Cardiomyopathy
Role in ARVC Maron B. - Minneapolis, USA
Delmar M. - New York, USA • ut of Hospital Cardiac Arrest
O
• AGUK Proteins Are Important in Ion Channel Diseases
M Chugh S. S. - Los Angeles, USA
Hatem S. - Paris, FRA • hat Are the Clinical Implications?
W
• hat Are the Clinical Implications?
W Viskin S. - Tel Aviv, ISR
Coronel R. - Amsterdam, NLD
• General Discussion
20 www.cardiostim.com

21. Cardiostim 2012
Basic Electrophysiology
Thursday June 14 / 14:00 - 15:30 Friday June 15 / 09:00 - 10:30
THE INTERCALATED DISC AND ROLE OF CaMKII IN ARRHYTHMIAS
ARRHYTHMOGENIC CARDIOMYOPATHY Chair:
Chair: Maier L. - Goettingen, DEU
Poelzing S. - Salt Lake City, USA Gilmour R. - Ithaca, USA
Ehrlich J. - Frankfurt, DEU
• aMKII Regulation of Ion Channels
C
• ased on Science, What Is the Best Name for Arrhythmogenic
B Pitt G. - Durham, USA
Right Ventricular Cardiomyopathy? • aMKII Regulation of RyR Receptors and Ca Cycling
C
McKenna W. - London, GBR Wehrens X. H. - Houston, USA
• ell-Cell Communication in ARVC
C • ole of CaMKII in Cardiac Arrhythmias
R
Greene K. - Chicago, USA Mohler P. J. - Columbus, USA
• rrhythmia Mechanisms and Therapy
A • aMKII as a Potential Antiarrhythmic Target
C
Calkins H. - Baltimore, USA Maier L. - Goettingen, DEU
• hat Is Needed for a Cure?
W • hat Are the Clinical Implications?
W
Thiene G. - Padova, ITA Rosenbaum D. S. - Cleveland, USA
• hat Are the Clinical Implications?
W
Marcus F. - Tucson, USA
Thursday June 14 / 16:00 - 17:30 Friday June 15 / 11:00 - 12:30
UNDERSTANDING ATRIAL FIBRILLATION ROLE OF THE AUTONOMIC NERVOUS SYSTEM
Chair: IN ARRHYTHMOGENESIS
Hocini M. - Bordeaux, FRA Chair:
Probst V. - Nantes, FRA Yamada K. - St. Louis, USA
Franz M. - Washington, USA
• otassium Channel Remodeling
P
Nattel S. - Montreal, CAN • ympathetic-Vagal Interactions in Conscious Dogs
S
• emodeling of Calcium Handling
R Lin S- F. - Indianapolis, USA
Dobrev D. - Heidelberg, DEU • agal Modulation of Atrial Arrhythmias
V
• Structural Remodeling Po S. - Oklahoma City, USA
Allessie M. - Maastricht, NLD • agal Modulation of Inflammation
V
• hat Are the Clinical Implications?
W Sabbah H. - Detroit, USA
Natale A. - Austin, USA • hat Are the Clinical Implications?
W
• General Discussion Goldberger J. - Chicago, USA
• General discussion
www.cardiostim.com 21

22. Advance program
Basic Electrophysiology
Friday June 15 / 14:00 - 15:30 Philippe Coumel Session
SMALL CONDUCTANCE CALCIUM-ACTIVATED Introduction: from Mechanism to Process.
POTASSIUM CHANNELS (SK) AND CARDIAC Paradigm Shift?
ARRHYTHMIAS Wednesday June 13 / 09:00 - 10:30
Chair: ATRIAL FIBRILLATION: DEALING WITH
Lakatta E. - Baltimore, USA
Opthof T. - Utrecht, NLD
COMPLEXITY
Chair:
• hat Are SK Channels?
W Guiraudon G.M.- London, CAN
Chiamvimonvat N. - Chicago, USA Klein G. J. - London, CAN
• K Channels and Ventricular Arrhythmias in Heart Failure
S
• ntrinsic Autonomic Cardiac Nervous System: New Physiology
I
Chen P- S. - Indianapolis, USA
or Deregulation? Has Neuroablation Predictable Long-Term
• K Channels Modulate Cardiogenesis
S Effects?
Liebau S. - Ulm, DEU Cardinal R. - Montreal, CAN
• K Channels and Genetic Basis of Atrial Fibrillation
S • nderstanding the Complexity of the Substrate of Human AF
U
Ellinor P. - Boston, USA Allessie M. - Maastricht, NLD
• hat Are the Clinical Implications?
W • hen Complexity Beats Ablation? Alternative Interventions to
W
Myerburg R. J. - Miami, USA Restore Chronotropic Function, and Stroke Prevention
Guiraudon G.M. - London, CAN
Friday June 15 / 16:00 - 17:30
ROLE OF miRNAs IN ARRHYTHMIA
SYNDROMES
Chair:
Grunnet M. - Copenhagen, DNK
Boyden P. - New York, USA
• hy All the Interest in miRNAs?
W
Pinto Y. - Amsterdam, NLD
• Hypertrophic Cardiomyopathy
Ackerman M. - Rochester, USA
• ong QT Syndrome
L
Wilde A. M. - Amsterdam Zuidoost, NLD
• Dilated Cardiomyopathy
Engelhardt S. - Munich, DEU
• hat Are the Clinical Implications?
W
Roden D. M. - Nashville, USA
22 www.cardiostim.com

23. Cardiostim 2012
Complex Electrophysiology and Ablation Techniques
Course Directors:
Scheinman M. - San Fransciso, USA
O’Neill M. - London, GBR
Probst V. - Nantes, FRA
Sacher F. - Bordeaux, FRA
Wednesday June 13 / 11:00 - 12:30 Wednesday June 13 / 16:00 - 17:30
ATRIAL FIBRILLATION ABLATION I ATRIAL FIBRILLATION ABLATION III
• echanisms of Atrial Fibrillation. Implication for Ablation
M • ryo Balloon Ablation of AF
C
Strategies Ellenbogen K. - Richmond, USA
Nattel S. - Montreal, CAN • atients Selection for AF Ablation
P
• eal Time Mapping to Guide Atrial Fibrillation Ablation
R O’Neill M. - London, GBR
Narayan S. - San Diego, USA • ow to Identify Targets and End-Points for Atrial Fibrillation
H
• MR Imaging:” Does It Have a Role in Atrial Fibrillation
“ Ablation?
Ablation? Asirvatham S. J. - Rochester, USA
Marrouche N. F. - Salt Lake City, USA • ong-Term Outcome for Atrial Fibrillation Ablation
L
• trial Fibrillation Ablation for Patients with Long Standing
A Knecht S. - Brussels, BEL
Persistent Atrial Fibrillation
Sanders P. - Adelaide, AUS
Wednesday June 13 / 14:00 - 15:30
ATRIAL FIBRILLATION ABLATION II
• ewer Left Atrial Appendage Occlusion and Ligation Devices
N
for Stroke Prevention: Should They Be Part of an Atrial
Fibrillation Procedure?
Lee R. J. - San Francisco, USA
• picardial Ablation of Atrial Fibrillation
E
Michaud G. F. - Boston, USA
• atheter Ablation of Atrial Fibrillation Using a Non-
C
Fluoroscopic Sensor Navigation Device
Hindricks G. - Leipzig, DEU
• ontact Monitoring and New Ablation Toys
C
Wright M. - London, USA
www.cardiostim.com 23

24. Advance program
Complex Electrophysiology and Ablation Techniques
Thursday June 14 / 09:00 - 10:30 Thursday June 14 / 14:00 - 15:30
ATRIAL FLUTTER ABLATION PAROXYSMAL SUPRAVENTRICULAR
• nusual forms (Double Loop, Lower Loop and Intra-Isthmus
U TACHYCARDIA ABLATION II
Reentry) • blation of the Patient with Atrio-Fascicular Pathways
A
Mounsey J. P. - Chapel Hill, USA Jackman W. M. - Oklahoma City, USA
• pproach to the Ablation of Post Atrial Fibrillation Induced Left
A • blation of Atrial Tachycardia/Accessory Pathways from the
A
Atrial Flutter Aortic Sinus
Knecht S. - Brussels, BEL Kuck K. H. - Hamburg, DEU
• iagnoses and Ablation of Right Sided Flutter
D • ow to Best Diagnose SVT Mechanisms?
H
Yagi T. - Sendai, JPN Callans D. - Philadelphia, USA
• resentation of Complex Cases (SVT)
P
Scheinman M. - San Fransciso, USA
Thursday June 14 / 11:00 - 12:30 Thursday June 14 / 16:00 - 17:30
PAROXYSMAL SUPRAVENTRICULAR Interactive session
TACHYCARDIA ABLATION I • nteractive session
I
• echanisms and Results of Ablative Therapy for Patients with
M Badhwar N. - San Francisco, USA
Focal Junctional Tachycardia Kalman J. M. - Parkville, AUS
Cheng J. - Houston, USA Kuck K. H. - Hamburg, DEU
Callans D. - Philadelphia, USA
• blation of Complex ANVRT Circuits
A
Badhwar N. - San Francisco, USA
• iagnoses, Therapy and Results of Ablative Therapy for
D
Patients with Manifest or Concealed Nodo-Fascicular
(Ventricular) Pathways
Badhwar N. - San Francisco, USA
• ocalization and Ablation of Atrial Tachycardias
L
Kalman J. M. - Parkville, AUS
24 www.cardiostim.com

25. Cardiostim 2012
Complex Electrophysiology and Ablation Techniques
Friday June 15 / 09:00 - 10:30 Friday June 15 / 14:00 - 15:30
VENTRICULAR TACHYCARDIA ABLATION I VENTRICULAR TACHYCARDIA ABLATION III -
• ole of Identifying and Ablating Late Potentials
R Debates
Jaïs P. - Bordeaux, FRA • atients with 1st Appropriate ICD Shock Should be Treated
P
• ecognition and Ablation of Intraseptal VT
R with Ablation
Bogun F. - Ann Arbor, USA PRO: Sapp J. - Halifax, CAN
• oes Cardiac MRI Identify the Critical VT Isthmus?
D CON: TBD
Dickfeld T. - Baltimore, USA • blation of AF: First Line Therapy in Electrical Storms
A
• he Role of Endocardial Unipolar Recordings for VT Ablation
T PRO: Boyle N. - Los Angeles, USA
Callans D. - Philadelphia, USA CON: Coromilas J. - New York, USA
Friday June 15 / 11:00 - 12:30 Friday June 15 / 16:00 - 17:30
VENTRICULAR TACHYCARDIA ABLATION II VENTRICULAR TACHYCARDIA ABLATION IV
• atheter Ablation of Fascicular Tachycardia in Practice
C • atheter Ablation of Patients with Arrhythmogenic Right
C
Nogami A. - Kanagawa, JPN Ventricular Dysplasia (ARVD)
• atheter Ablation of VT from Papillary Muscles
C Reddy V. Y. - Boston, USA
Kay N. - Birmingham, USA • atheter Ablation of Patients with VT and Systemic Disease
C
• F Ablation in Post MI Patients
V (Sarcoid/Amyloid/Iron Overload/Myotonic Dystrophy)
Snumowski L. - Warsaw, POL Arruda M. - Case Western, USA
• ong-Term Outcome after VF Ablation
L • blation of the Patient with Ischemic VT
A
Hocini M. - Bordeaux, FRA Soejima K. - Kawasaki, JPN
• ipolar Voltage Map vs. MR for Detection of Myocardial Scar
B
Gerstenfeld E. P. - Philadelphia, USA
www.cardiostim.com 25

26. Advance program
Complex Electrophysiology and Ablation Techniques
Cases Discussion in Electrophysiology
Organized by
Klein G.J. - London, CAN
Sacher F. - Bordeaux-Pessac, FRA
O’Neill M. - London, GBR
Speakers are invited to present 1 or 2 cases they found instructive or challenging. The problem might be diagnostic or related to
ablation complexity.
Speakers should be prepared to be interrupted and participate in dialogue during the presentation and consider this in the length
of their presentation.
Saturday June 16 / 9:00 - 10:30 Saturday June 16 / 11:00 - 12:30
THE CHALLENGING CASE - Part I THE CHALLENGING CASE - Part II
Chair: Chair:
Klein G. J. - London, CAN Klein G. J. - London, CAN
Callans D. - Philadelphia, USA Callans D. - Philadelphia, USA
O’Neill M. - London, GBR O’Neill M. - London, GBR
Skanes A. - London, CAN Skanes A. - London, CAN
State-of-the-Art in the Brugada Syndrome
Organized by
Sacher F. - Bordeaux-Pessac, FRA
Friday June 15 / 09:00 - 10:30 Friday June 15 / 11:00 - 12:30
THERAPEUTIC OPTIONS IN BRUGADA UNSOLVED ISSUES IN BRUGADA SYNDROME
SYNDROME Chair:
Wilde A. M. - Amsterdam Zuidoost, NLD
• isk Stratification in Brugada Syndrome
R Antzelevitch C. - Utica, USA
Delise P. - Trevise, ITA
• utcome after ICD Implantation
O • CN5A: Which Role in Brugada Syndrome?
S
Sacher F. - Bordeaux-Pessac, FRA Probst V. - Nantes, FRA
• F Ablation in Brugada Syndrome
V • rugada Syndrome Mechanism: Depolarization/Repolarization
B
Nademanee K. - Los Angeles, USA or Different Entities with a Same ECG Pattern
Postema P.G. - Amsterdam, NLD
• alue of Electrophysiological Study for Risk Stratification: The
V
PRELUDE Study
Priori S. G. - Pavia, ITA
26 www.cardiostim.com

27. Cardiostim 2012
Complex Electrophysiology and Ablation Techniques
Novel Approaches to Apply Mechanistic Insights to Complex Human Arrhythmias
Organized by
E. Pruvot - Lausanne, CHE S. Narayan - San Diego, USA
Goals: To discuss the implementation and practical application of principles and insights from basic science to understand and treat
human arrhythmias. Because the detailed mapping and tissue analyses for in silico, in vitro and in vivo animal models often cannot
be applied in patients, this session will also discuss technical innovations that have enabled successful translational patient studies.
Thursday June 14 / 14:00 - 15:30 Thursday June 14 / 16:00 - 17:30
MECHANISTIC APPROACHES TO COMPLEX MECHANISTICALLY-GUIDED THERAPIES FOR
ARRHYTHMIAS - PART I: REPOLARIZATION HUMAN CARDIAC FIBRILLATION - PART II -
ALTERNANS – TRANSLATING FUNDAMENTAL ATRIAL ARRHYTHMIAS
OBSERVATIONS TO CLINICAL PRACTICE FOR Chair:
ATRIAL AND VENTRICULAR ARRHYTHMIAS Berenfeld O. - Ann Arbor, USA
Chair:
Pruvot E. - Lausanne, CHE • asic Science of Atrial Fibrillatory Sources: The Role of Rotors
B
Narayan S. - San Diego, USA vs Multiple Wavelets
Jalife J. - Ann Arbor, USA
• rom Pulsus to Pulseless: The Saga of Cardiac Repolarization
F • ocalized Rotors and Focal Beats in Human Atrial Fibrillation
L
Alternans Narayan S. - San Diego, USA
Rosenbaum D. S. - Cleveland, USA • linical Application of Noninvasive Electrocardiographic
C
• ntermittent Atrial Tachycardia Promotes Repolarization
I Imaging (ECGI)
Alternans and Susceptibility to AF in a Free-Behaving Sheep Cuculich P. - St Louis, USA
Model • lectrogram Correlates of Localized Sources During AF
E
Pruvot E. - Lausanne, CHE Mansour M. - Boston, USA
• trial Repolarization Alternans as a Dynamic Substrate
A • ole of Imaging and Ablating Structural Obstacles to Treat
R
Promoting Wavebreaks in Human Paroxysmal and Persistent Human AF
AF Marrouche N. F. - Salt Lake City, USA
Narayan S. - San Diego, USA
• ERCA2A Overexpression as a Molecular Intervention to
S
Suppress Repolarization Alternans and Susceptibility of
Cardiac Fibrillation
Cutler M. - Cleveland, USA
• ntracardiac Repolarization Alternans/Variability Predicts
I
Imminent Ventricular Tachyarrhythmias in ICD Recipients
Swerdlow C. D. - Los Angeles, USA
www.cardiostim.com 27

28. Advance program
Complex Electrophysiology and Ablation Techniques
Friday June 15 / 09:00 - 10:30 Computer Modelling
MECHANISTICALLY-GUIDED APPROACHES TO Organized by
Maxime Sermasant - Sophia Antipolis, FRA from INRIA
HUMAN CARDIAC FIBRILLATION - PART III -
(Institut National de Recherche en Informatique et Automatique)
VENTRICULAR ARRHYTHMIAS
Chair:
Shivkumar K. - San Diego, USA
Thursday June 14 / 11:00 - 12:30
• rigger Mechanisms for Human Ventricular Fibrillation
T COMPUTATIONAL ELECTROPHYSIOLOGY:
Knecht S. - Bordeaux, FRA
NOVEL TOOLS TO IMPROVE CLINICAL
• ecent Developments in Defibrillation and in Understanding
R
Ventricular Fibrillation
UNDERSTANDING
Ideker R. - Birmingham, USA Chair:
Panfilov A. V. - Gent, BEL
• hat Is the Optimal Mapping Approach to Guide Ablation of
W
Rhode K. - London, GBR
Human Ventricular Tachyarrhythmias?
Shivkumar K. - Los Angeles, USA
• lectrotonic Modulation of Cardiac Repolarization in Health
E
• ignal Processing Approaches to Guide Complex Ablation in
S
and Disease: Insights from a Combined Computational and
the Atria and Ventricles
Experimental Study
Chen S.A. - Taipei, TWN
Bernus O. - Bordeaux-Pessac, FRA
• ignal Processing Insights into the Mechanisms of Human
S
• lectro-Mechanical Interaction – Is This Something the
E
Ventricular Arrhythmias
Clinical Electrophysiologist Has to Care about or Is This only of
Krummen D.E. - San Diego, USA
Interest to the Cellular Researcher?
Bijnens B. - Barcelona, ESP
• lectrical and Structural Characteristics of Border Zone in
E
Infarcted Swine: Insights from 3D MR Image-Based Computer
Models, Histopathology and EP Data
Pop M. - Toronto, CAN
• ardiac Radiofrequency Ablation Planning from Personalized
C
Biophysical Models
Delingette H. - Sophia-Antipolis, FRA
28 www.cardiostim.com

29. Cardiostim 2012
Treatments of Atrial Fibrillation
Advances and Controversies in Atrial Fibrillation (ACAF)
Chairman:
Naccarelli G. V. - Hershey, USA
Blanc J.J. - Brest, FRA
Lévy S. - Marseille, FRA
Unrestricted Educational Support: sanofi aventis
Thursday June 14 / 09:00 - 10:30 Thursday June 14 / 14:00 - 15:30
ATRIAL FIBRILLATION I ATRIAL FIBRILLATION III
Chair: Chair:
Naccarelli G. V. - Hershey, USA Santini M. - Rome, ITA
Boriani G. - Bologna, ITA Breithardt G. - Münster, DEU
• arly Attempts at Rhythm Control Slows Progression of AF
E • ovel Anticoagulants: Where Are We in 2012?
N
Crijns H. J. - Maastricht, NLD Naccarelli G. V. - Hershey, USA
• as Basic Science Helped Us Develop Better Pharmacologic
H • an Newer Anticoagulants Be Used Safely for Cardioversion
C
and Ablative Therapies for AF? of AF Patients?
Allessie M. - Maastricht, NLD Aliot E. - Nancy, FRA
• pstream Therapy of AF – Is It All over but the Shouting?
U • ntiarrhythmic/Anticoagulant Drug Interactions: What Do We
A
Dorian P. - Toronto, CAN Know?
Tamargo J. - Madrid, ESP
Thursday June 14 / 11:00 - 12:30 Thursday June 14 / 16:00 - 17:30
ATRIAL FIBRILLATION II ATRIAL FIBRILLATION IV
Chair: Chair:
van Gelder I. C. - Groningen, NLD Lévy S. - Marseille, FRA
Capucci A. - Ancona, ITA Vardas P. E. - Heraklion, GRC
• ronedarone in 2012: What is New?
D • symptomatic AF: Prognostic Implications
A
Le Heuzey J. Y. - Paris , FRA Blanc J. J. - Brest, FRA
• ALLAS: Why Was It Performed? Where Are We?
P • s Catheter Ablation of AF Prothrombotic or Antithrombotic?
I
Hohnloser S. - Frankfurt, DEU Packer D. L. - Rochester, USA
• ronedarone and Ranolazine: Is a Combination Drug a Good
D • ole of Novel Anticoagulants During AF Ablation Procedures?
R
Idea ? Cappato R. - San Donato Milanese (MI), ITA
Antzelevitch C. - Utica, USA
www.cardiostim.com 29